中华内分泌外科杂志
中華內分泌外科雜誌
중화내분비외과잡지
CHINESE JOURNAL OF ENDOCRINE SURGERY
2012年
2期
120-123
,共4页
单珊%刘璇%李含%陈恒%徐宽枫%张弢%张梅%杨涛
單珊%劉璇%李含%陳恆%徐寬楓%張弢%張梅%楊濤
단산%류선%리함%진항%서관풍%장도%장매%양도
微囊%壳聚糖%磷酰胆碱%生物相容性%糖尿病%胰岛移植
微囊%殼聚糖%燐酰膽堿%生物相容性%糖尿病%胰島移植
미낭%각취당%린선담감%생물상용성%당뇨병%이도이식
Microcapsule%Chitosan%Phosphorylcholine%Biocompatibility%Diabetes%Islet transplantation
目的 探讨磷酰胆碱修饰的新型海藻酸-壳聚糖微囊包裹胰岛对微囊生物相容性的影响.方法 应用静电微囊发生技术获得磷酰胆碱修饰的海藻酸-壳聚糖微囊;利用考马斯亮蓝法分别测定单纯壳聚糖和磷酰胆碱修饰的壳聚糖对牛血清白蛋白的吸附量;将海藻酸-壳聚糖-磷酰胆碱微囊(实验组)和海藻酸-壳聚糖微囊(对照组)分别植入小鼠腹腔,4周后回收微囊,HE染色评价囊周纤维化情况;采用葡萄糖刺激试验评价微囊胰岛和单纯胰岛的胰岛素释放功能.结果 单位质量的壳聚糖及磷酰胆碱修饰物所吸附的蛋白质量分别为189.4 μg/mg和90.5μg/mg(t=5.549,P<0.05),差异有统计学意义;微囊植入腹腔后,实验组囊表面细胞反应较对照组轻微,未见明显的纤维化形成;实验组微囊包裹胰岛与单纯胰岛在低糖溶液中,胰岛素浓度分别是(3.298±1.680) μIU/ml和(4.299±1.159) μIU/ml(t=1.096,P>0.05),而在高糖溶液中分别是(11.783 ±4.175) μIU/ml和(12.875±2.268) μIU/ml(=0.514,P>0.05),差异均无统计学意义.结论 磷酰胆碱修饰可提高海藻酸-壳聚糖微囊的生物相容性,同时不影响微囊胰岛生物学功能,更适用于微囊胰岛移植治疗糖尿病.
目的 探討燐酰膽堿脩飾的新型海藻痠-殼聚糖微囊包裹胰島對微囊生物相容性的影響.方法 應用靜電微囊髮生技術穫得燐酰膽堿脩飾的海藻痠-殼聚糖微囊;利用攷馬斯亮藍法分彆測定單純殼聚糖和燐酰膽堿脩飾的殼聚糖對牛血清白蛋白的吸附量;將海藻痠-殼聚糖-燐酰膽堿微囊(實驗組)和海藻痠-殼聚糖微囊(對照組)分彆植入小鼠腹腔,4週後迴收微囊,HE染色評價囊週纖維化情況;採用葡萄糖刺激試驗評價微囊胰島和單純胰島的胰島素釋放功能.結果 單位質量的殼聚糖及燐酰膽堿脩飾物所吸附的蛋白質量分彆為189.4 μg/mg和90.5μg/mg(t=5.549,P<0.05),差異有統計學意義;微囊植入腹腔後,實驗組囊錶麵細胞反應較對照組輕微,未見明顯的纖維化形成;實驗組微囊包裹胰島與單純胰島在低糖溶液中,胰島素濃度分彆是(3.298±1.680) μIU/ml和(4.299±1.159) μIU/ml(t=1.096,P>0.05),而在高糖溶液中分彆是(11.783 ±4.175) μIU/ml和(12.875±2.268) μIU/ml(=0.514,P>0.05),差異均無統計學意義.結論 燐酰膽堿脩飾可提高海藻痠-殼聚糖微囊的生物相容性,同時不影響微囊胰島生物學功能,更適用于微囊胰島移植治療糖尿病.
목적 탐토린선담감수식적신형해조산-각취당미낭포과이도대미낭생물상용성적영향.방법 응용정전미낭발생기술획득린선담감수식적해조산-각취당미낭;이용고마사량람법분별측정단순각취당화린선담감수식적각취당대우혈청백단백적흡부량;장해조산-각취당-린선담감미낭(실험조)화해조산-각취당미낭(대조조)분별식입소서복강,4주후회수미낭,HE염색평개낭주섬유화정황;채용포도당자격시험평개미낭이도화단순이도적이도소석방공능.결과 단위질량적각취당급린선담감수식물소흡부적단백질량분별위189.4 μg/mg화90.5μg/mg(t=5.549,P<0.05),차이유통계학의의;미낭식입복강후,실험조낭표면세포반응교대조조경미,미견명현적섬유화형성;실험조미낭포과이도여단순이도재저당용액중,이도소농도분별시(3.298±1.680) μIU/ml화(4.299±1.159) μIU/ml(t=1.096,P>0.05),이재고당용액중분별시(11.783 ±4.175) μIU/ml화(12.875±2.268) μIU/ml(=0.514,P>0.05),차이균무통계학의의.결론 린선담감수식가제고해조산-각취당미낭적생물상용성,동시불영향미낭이도생물학공능,경괄용우미낭이도이식치료당뇨병.
Objective To explore whether the biocompatibility of phosphorylcholine (PC) modified alginate-chitosan microcapsules could be improved. Methods PC modified alginate-chitosan microcapsules were obtained by high-voltage electrostatic system.Bradford method was adopted to determine the adsorption amounts of bovine serum albumin by chitosan alone and PC modified chitosan.Alginate-chitosan-PC microcapsules (experimental group) and alginate-chitosan microcapsules ( control group) were respectively implanted into the peritoneal cavity of mice and retrieved 4 weeks after transplantation.Fibrosis of the capsules was evaluated by HE staining.Glucose stimulated insulin secretion (GSIS) assay was used to assess the insulin secretion response of encapsulated and nonencapsulated rat islets. Results The adsorption amount of protein was 189.4 μg/mg and 90.5 μg/mg respectively by chitosan alone and PC modified chitosan.The difference had statistical significance ( t =5.549, P < 0.05 ).In contrast to the control group, the cellular reaction on the surface of the modified microcapsules was weaker, with no obvious fibrosis found.The insulin secreted by encapsulated islets and nonencapsulated islets was( 3.298 ± 1.680 ) μIU/ml VS (4.299 ± 1.159 ) μIU/ml ( t =1.096, P > 0.05 ) in response to low-glucose stimulus and( 11.783 ± 4.175 ) μIU/ml VS ( 12.875 ± 2.268 ) μIU/ml ( t =0.514, P > 0.05 ) in response to high-glucose stimulus.Conclusions PC can improve the biocompatibility of alginate-chitosan microcapsules, with no effect on the biological function of encapsulated islets.It may be more appropriate to use modified microcapsules encapsulating islets for transplantation.